ES2190456T3 - Combinacion de inhibidores de la proteasa del vih. - Google Patents

Combinacion de inhibidores de la proteasa del vih.

Info

Publication number
ES2190456T3
ES2190456T3 ES95930118T ES95930118T ES2190456T3 ES 2190456 T3 ES2190456 T3 ES 2190456T3 ES 95930118 T ES95930118 T ES 95930118T ES 95930118 T ES95930118 T ES 95930118T ES 2190456 T3 ES2190456 T3 ES 2190456T3
Authority
ES
Spain
Prior art keywords
combination
hiv protease
hiv
protease inhibitors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95930118T
Other languages
English (en)
Inventor
Paul J Deutsch
Emilio A Emini
Joseph P Vacca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2190456T3 publication Critical patent/ES2190456T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA COMBINACION DEL COMPUESTO J INHIBIDOR DE PROTEASA HIV Y UNO O MAS DE OTROS POTENTES INHIBIDORES DE LA PROTEASA HIV ES UTIL EN LA INHIBICION DE LA PROTEASA HIV, LA PREVENCION O TRATAMIENTO DE LA INFECCION POR HIV, EN COMPUESTOS, SALES ACEPTABLES FARMACEUTICAMENTE, INGREDIENTES DE COMPOSICIONES FARMACEUTICAS, EN COMBINACION O NO CON OTROS ANTIVIRALES, INMUNOMODULADORES, ANTIBIOTICOS O VACUNAS. TAMBIEN SE DESCRIBEN METODOS PARA TRATAR EL SIDA Y METODOS PARA PREVENIR O TRATAR LA INFECCION POR HIV.
ES95930118T 1994-08-11 1995-08-07 Combinacion de inhibidores de la proteasa del vih. Expired - Lifetime ES2190456T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28947494A 1994-08-11 1994-08-11
US33936994A 1994-11-14 1994-11-14
US49246195A 1995-07-20 1995-07-20

Publications (1)

Publication Number Publication Date
ES2190456T3 true ES2190456T3 (es) 2003-08-01

Family

ID=27403895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95930118T Expired - Lifetime ES2190456T3 (es) 1994-08-11 1995-08-07 Combinacion de inhibidores de la proteasa del vih.

Country Status (20)

Country Link
EP (1) EP0774969B8 (es)
JP (1) JPH10504036A (es)
KR (1) KR970704441A (es)
CN (1) CN1101190C (es)
AT (1) ATE232727T1 (es)
AU (1) AU698664B2 (es)
CA (1) CA2197207C (es)
CY (1) CY2360B1 (es)
CZ (1) CZ292577B6 (es)
DE (1) DE69529678T2 (es)
DK (1) DK0774969T3 (es)
ES (1) ES2190456T3 (es)
FI (1) FI970565A (es)
HU (1) HUT76540A (es)
IL (1) IL114808A (es)
MX (1) MX9701121A (es)
NO (1) NO314168B1 (es)
PL (1) PL181578B1 (es)
SK (1) SK18197A3 (es)
WO (1) WO1996004913A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
AU716760B2 (en) * 1996-11-08 2000-03-09 Japan Energy Corporation Aids therapeutic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US517041A (en) * 1894-03-27 Fruit-picker
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2096408C (en) * 1990-11-19 2005-02-08 Gary Anthony Decrescenzo Retroviral protease inhibitors
EP0558657B1 (en) * 1990-11-19 1997-01-08 Monsanto Company Retroviral protease inhibitors
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
EP0541168B1 (en) * 1991-11-08 1998-03-11 Merck & Co. Inc. HIV protease inhibitors useful for the treatment of aids
DK0727419T3 (da) * 1992-12-29 2002-06-10 Abbott Lab Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease

Also Published As

Publication number Publication date
DK0774969T3 (da) 2003-03-31
EP0774969B1 (en) 2003-02-19
CY2360B1 (en) 2004-06-04
WO1996004913A1 (en) 1996-02-22
DE69529678D1 (de) 2003-03-27
CN1160350A (zh) 1997-09-24
SK18197A3 (en) 1997-09-10
EP0774969A1 (en) 1997-05-28
NO970632L (no) 1997-04-10
IL114808A0 (en) 1995-12-08
IL114808A (en) 1999-10-28
MX9701121A (es) 1997-05-31
AU698664B2 (en) 1998-11-05
KR970704441A (ko) 1997-09-06
FI970565A0 (fi) 1997-02-10
AU3361195A (en) 1996-03-07
DE69529678T2 (de) 2003-09-25
HUT76540A (en) 1997-09-29
CZ292577B6 (cs) 2003-10-15
PL181578B1 (pl) 2001-08-31
CN1101190C (zh) 2003-02-12
NO314168B1 (no) 2003-02-10
PL318506A1 (en) 1997-06-23
NO970632D0 (no) 1997-02-11
CA2197207A1 (en) 1996-02-22
FI970565A (fi) 1997-02-10
CZ38997A3 (en) 1997-11-12
EP0774969B8 (en) 2003-07-02
CA2197207C (en) 2006-10-17
ATE232727T1 (de) 2003-03-15
JPH10504036A (ja) 1998-04-14

Similar Documents

Publication Publication Date Title
DE69228106D1 (de) HIV-Protease-Inhibitoren
ATE377011T1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer
MY109834A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
ATE252081T1 (de) Neue hiv-protease-inhibitoren
DZ1766A1 (fr) Inhibiteurs de vih protéase utiles pour le traitement du sida.
ATE215952T1 (de) Hiv-proteaseinhibitoren
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.
ECSP982741A (es) Terapia combinada para el tratamiento del sida